Your browser is no longer supported. Please, upgrade your browser.
Settings
SPPI Spectrum Pharmaceuticals, Inc. daily Stock Chart
SPPI [NASD]
Spectrum Pharmaceuticals, Inc.
Index- P/E- EPS (ttm)-0.85 Insider Own3.00% Shs Outstand80.21M Perf Week-1.06%
Market Cap374.58M Forward P/E- EPS next Y-0.93 Insider Trans0.00% Shs Float72.16M Perf Month-12.05%
Income-56.50M PEG- EPS next Q-0.32 Inst Own69.80% Short Float10.22% Perf Quarter-30.19%
Sales156.80M P/S2.39 EPS this Y-10.80% Inst Trans17.10% Short Ratio8.46 Perf Half Y-30.51%
Book/sh3.44 P/B1.36 EPS next Y16.20% ROA-13.30% Target Price9.00 Perf Year-18.78%
Cash/sh1.94 P/C2.40 EPS next 5Y- ROE-25.90% 52W Range4.14 - 7.74 Perf YTD-22.55%
Dividend- P/FCF- EPS past 5Y3.80% ROI-13.20% 52W High-39.66% Beta1.49
Dividend %- Quick Ratio3.40 Sales past 5Y17.00% Gross Margin81.30% 52W Low12.80% ATR0.24
Employees212 Current Ratio3.50 Sales Q/Q-24.70% Oper. Margin-30.30% RSI (14)34.66 Volatility3.39% 5.25%
OptionableYes Debt/Eq0.43 EPS Q/Q-888.50% Profit Margin-36.00% Rel Volume0.51 Prev Close4.58
ShortableYes LT Debt/Eq0.43 EarningsAug 09 AMC Payout- Avg Volume872.07K Price4.67
Recom2.00 SMA20-6.60% SMA50-18.95% SMA200-22.89% Volume448,143 Change1.97%
Nov-05-15Reiterated RBC Capital Mkts Outperform $13 → $12
Aug-07-15Reiterated RBC Capital Mkts Outperform $12 → $13
Apr-02-15Initiated FBR Capital Outperform $9
Feb-23-15Downgrade ROTH Capital Buy → Neutral $15 → $7
Jul-15-14Upgrade R. F. Lafferty Sell → Neutral $7.50
Oct-07-13Initiated HC Wainwright Buy $15
May-29-13Initiated Burrill Institutional Research Mkt Outperform $12
Mar-13-13Reiterated RBC Capital Mkts Outperform $19 → $16
Mar-13-13Downgrade WallachBeth Buy → Sell $20 → $5.50
May-02-11Reiterated MLV Capital Buy $12.50 → $20.50
Mar-25-11Initiated RBC Capital Mkts Outperform $12
Dec-07-10Reiterated Morgan Joseph Buy $8 → $10
Jan-12-10Upgrade Morgan Joseph Hold → Buy $8
Oct-14-09Reiterated Rodman & Renshaw Mkt Outperform $10 → $8
Sep-08-09Downgrade Morgan Joseph Buy → Hold
Sep-09-08Initiated Morgan Joseph Buy $5
Apr-23-08Downgrade Oppenheimer Outperform → Perform
Mar-18-08Downgrade Brean Murray Buy → Hold
Nov-01-07Reiterated Friedman Billings Mkt Perform $5.50 → $4
Oct-31-07Reiterated Rodman & Renshaw Mkt Outperform $8 → $6
Sep-30-16 12:55PM  SECURITIES NOTICE: Rosen Law Firm Reminds Spectrum Pharmaceuticals, Inc. Investors of Important Deadline in Class Action Filed by Firm- SPPI PR Newswire
Sep-28-16 06:18PM  IMPORTANT SPECTRUM PHARMACEUTICALS, INC. SHAREHOLDER ALERT: Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action lawsuit has been filed on behalf of shareholders of Spectrum Pharmaceuticals, Inc. Accesswire
10:10AM  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Spectrum Pharmaceuticals Inc. (SPPI) and Lead Plaintiff Deadline: November 21, 2016 GlobeNewswire
07:37AM  Inside The FDA: Spectrum Pharmaceuticals, Inc. (SPPI) and its Bladder Cancer Treatment, Apaziquone at Insider Monkey
Sep-27-16 02:13PM  Robbins Arroyo LLP: Spectrum Pharmaceuticals, Inc. (SPPI) Misled Shareholders According to a Recently Filed Class Action Business Wire
Sep-23-16 11:23AM  INVESTOR ALERT: Investigation of Spectrum Pharmaceuticals, Inc. Announced by Law Offices of Howard G. Smith Business Wire
10:49AM  SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Spectrum Pharmaceuticals, Inc. - SPPI GlobeNewswire
09:30AM  SPECTRUM PHARMACEUTICALS INVESTOR ALERT: Hagens Berman Alerts Spectrum Pharmaceuticals Inc. Investors to Class Action and Lead Plaintiff Deadline GlobeNewswire
Sep-22-16 12:50PM  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Spectrum Pharmaceuticals Inc. (SPPI) and Lead Plaintiff Deadline: November 21, 2016 PR Newswire +7.61%
Sep-21-16 04:53PM  SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Spectrum Pharmaceuticals, Inc. To Contact The Firm Business Wire
02:24PM  Glancy Prongay & Murray LLP Commences Investigation on Behalf of Spectrum Pharmaceuticals, Inc. Investors Business Wire
12:35PM  EQUITY ALERT: Rosen Law Firm Files Securities Class Action Against Spectrum Pharmaceuticals, Inc. - SPPI Business Wire
09:30AM  SPECTRUM PHARMACEUTICALS INVESTOR ALERT: Hagens Berman is Investigating Possible Securities Law Violations by Spectrum Pharmaceuticals Inc. and Officers GlobeNewswire
07:08AM  Hynes Keller & Hernandez, LLC Announces Investigation of Spectrum Pharmaceuticals, Inc. (SPPI) PR Newswire
Sep-20-16 04:03PM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces the Commencement of an Investigation Involving Possible Securities Fraud Violations by Spectrum Pharmaceuticals, Inc. Business Wire
10:50AM  SHAREHOLDER ALERT: Goldberg Law PC Announces an Investigation of Spectrum Pharmaceuticals, Inc. Business Wire
09:31AM  SPECTRUM PHARMACEUTICALS NOTIFICATION: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In Spectrum Pharmaceuticals, Inc. To Contact The Firm PR Newswire
Sep-19-16 07:19PM  IMPORTANT SHAREHOLDER ALERT: Khang & Khang LLP Announces an Investigation of Spectrum Pharmaceuticals, Inc. and Encourages Investors with Losses to Contact the Firm Business Wire
06:10PM  EQUITY ALERT: Rosen Law Firm Announces Investigation of Securities Claims Against Spectrum Pharmaceuticals, Inc. Business Wire
11:33AM  IMPORTANT INVESTOR ALERT: Lundin Law PC Announces an Investigation of Spectrum Pharmaceuticals, Inc. and Advises Investors with Losses to Contact the Firm Business Wire
10:15AM  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Spectrum Pharmaceuticals Inc. (SPPI) PR Newswire
Sep-16-16 07:07PM  INVESTOR ALERT: Goldberg Law PC Announces an Investigation of Spectrum Pharmaceuticals, Inc. Business Wire
01:20PM  Block & Leviton LLP Investigates Spectrum Pharmaceuticals After Revelation That Company Concealed Discouraging Advice From FDA PR Newswire
11:47AM  Spectrum Pharma, FDA and the Buried Truth About a Bladder Cancer Drug Meeting
09:30AM  Two Biotechs With Bad News This Week: What Happens Now? at Insider Monkey
Sep-15-16 05:29PM  Spectrum (SPPI) Down, Qapzola Fails to Impress FDA Panel
08:56AM  FDA AdCom Votes on Pfizer and Spectrum Drugs - What Next?
Sep-14-16 02:51PM  Spectrum bladder cancer drug not effective - U.S. FDA panel Reuters -8.20%
02:21PM  SPECTRUM PHARMACEUTICALS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits
02:15PM  Spectrum Pharmaceuticals (SPPI) Stock Slumps on FDA Ruling
01:25PM  Spectrum Pharmaceuticals' stock drops after cancer treatment voted down by FDA committee at MarketWatch
01:06PM  FDA Advisory Committee Votes that Qapzola (apaziquone) Has Not Shown Substantial Evidence of a Treatment Effect Over Placebo Business Wire
08:47AM  Biotech Stock Roundup: Horizon-Raptor Acquisition Deal, Geron Down on Pipeline News
Sep-13-16 09:30AM  The Zacks Analyst Blog Highlights: Spectrum Pharmaceuticals, Amgen, AbbVie and Vertex Pharmaceuticals
Sep-12-16 09:23AM  3 Drug Stocks That Could Benefit from Key FDA Events in Sep 2016 +5.76%
Sep-07-16 09:30AM  Biotech Stock Roundup: CoLucid Soars on Migraine Data, Dynavax Drug FDA Panel Meeting Cancelled
Aug-31-16 11:51AM  ETFs with exposure to Spectrum Pharmaceuticals, Inc. : August 31, 2016
Aug-23-16 02:02PM  Our Take On Spectrum Pharmaceuticals, Inc. (SPPI)s Near Term Panel Review at Insider Monkey
Aug-18-16 01:04PM  SPECTRUM PHARMACEUTICALS INC Financials
Aug-15-16 10:52AM  ETFs with exposure to Spectrum Pharmaceuticals, Inc. : August 15, 2016
Aug-12-16 12:28PM  Spectrum Pharmaceuticals, Inc. :SPPI-US: Earnings Analysis: Q2, 2016 By the Numbers : August 12, 2016
Aug-11-16 08:14AM  Spectrum Pharmaceuticals, Inc. breached its 50 day moving average in a Bearish Manner : SPPI-US : August 11, 2016
Aug-09-16 04:56PM  Spectrum Pharma reports 2Q loss
04:04PM  SPECTRUM PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements
04:00PM  Spectrum Pharmaceuticals Reports Second Quarter 2016 Financial Results and Pipeline Update Business Wire
07:07AM  Q2 2016 Spectrum Pharmaceuticals Inc Earnings Release - Time Not Supplied
Aug-04-16 03:18PM  ETFs with exposure to Spectrum Pharmaceuticals, Inc. : August 4, 2016
Aug-02-16 07:00AM  Spectrum Pharmaceuticals Announces Second Quarter 2016 Financial Results Teleconference and Webcast Business Wire
Jul-20-16 12:53PM  ETFs with exposure to Spectrum Pharmaceuticals, Inc. : July 20, 2016
Jul-13-16 07:00AM  Spectrum Pharmaceuticals Settles FOLOTYN® (pralatrexate injection) ANDA Patent Litigation Business Wire
06:29AM  SPECTRUM PHARMACEUTICALS INC Files SEC form 8-K, Other Events
Jul-06-16 02:41PM  ETFs with exposure to Spectrum Pharmaceuticals, Inc. : July 6, 2016
07:00AM  Spectrum Pharmaceuticals to Present Corporate Update at the Cantor Fitzgeralds 2nd Annual Healthcare Conference on July 13th Business Wire
Jul-01-16 05:15PM  SPECTRUM PHARMACEUTICALS INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders
Jun-28-16 03:52PM  Forget Valeant, Invest in These Attractive Drug Stocks Instead
Jun-21-16 01:14PM  ETFs with exposure to Spectrum Pharmaceuticals, Inc. : June 21, 2016
Jun-09-16 06:02AM  SPECTRUM PHARMACEUTICALS INC Files SEC form 8-K, Other Events
Jun-01-16 07:00AM  Spectrum Pharmaceuticals to Present Corporate Update at the Jefferies 2016 Healthcare Conference on June 8th Business Wire
May-31-16 07:02AM  SPECTRUM PHARMACEUTICALS INC Files SEC form 8-K, Other Events
May-25-16 07:06AM  SPECTRUM PHARMACEUTICALS INC Files SEC form 8-K, Other Events
May-18-16 10:53PM  ETFs with exposure to Spectrum Pharmaceuticals, Inc. : May 19, 2016
May-17-16 04:10PM  Spectrum Pharmaceuticals, Inc. :SPPI-US: Earnings Analysis: Q1, 2016 By the Numbers
May-11-16 03:03PM  Is Spectrum Pharmaceuticals Still a Buy After Surging Higher in April? at Motley Fool
May-06-16 05:39PM  SPECTRUM PHARMACEUTICALS INC Files SEC form 10-Q, Quarterly Report +11.72%
01:27PM  Edited Transcript of SPPI earnings conference call or presentation 5-May-16 8:30pm GMT
07:00AM  Spectrum Pharmaceuticals Highlights an Oral Presentation on Apaziquone at the 2016 Annual Meeting of the American Urological Association Education and Research Inc. (AUA) in San Diego, California, May 6-10, 2016 Business Wire
May-05-16 04:25PM  Spectrum Pharma reports 1Q loss -8.05%
04:05PM  SPECTRUM PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements
04:00PM  Spectrum Pharmaceuticals Reports First Quarter 2016 Financial Results and Pipeline Update Business Wire
07:07AM  Q1 2016 Spectrum Pharmaceuticals Inc Earnings Release - After Market Close CCBN
May-03-16 07:00AM  Spectrum Pharmaceuticals to Present Corporate Update at the Bank of America Merrill Lynch 2016 Healthcare Conference on May 10th Business Wire
Apr-28-16 07:00AM  Spectrum Pharmaceuticals Announces First Quarter 2016 Financial Results Teleconference and Webcast Business Wire
Apr-20-16 01:31AM  [$$] Companies Wind Up in the Penalty Box on Executive Pay at The Wall Street Journal
Apr-19-16 07:24PM  [$$] Companies Wind Up in the 'Penalty Box' on Executive Pay at The Wall Street Journal
Apr-07-16 12:57PM  Four Biotech Stocks To Consider As The Sector Breaks Out Accesswire
10:06AM  Existing Chemotherapy Drugs for Lymphoma
09:30AM  Six Technologies That Will Change Healthcare Accesswire
Mar-28-16 09:39AM  ETFs with exposure to Spectrum Pharmaceuticals, Inc. : March 28, 2016
Mar-24-16 04:56PM  SPECTRUM PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers
Mar-15-16 07:00AM  FDA Grants Spectrum Pharmaceuticals Approval of EVOMELA (melphalan) for Injection Business Wire
Mar-14-16 05:27PM  SPECTRUM PHARMACEUTICALS INC Files SEC form 10-K, Annual Report
04:07PM  ETFs with exposure to Spectrum Pharmaceuticals, Inc. : March 14, 2016
12:39PM  XLV Rose Last Week, but Did It Reach Its 100-Day Moving Average?
12:29PM  Spectrum Pharmaceuticals, Inc. :SPPI-US: Earnings Analysis: Q4, 2015 By the Numbers
Mar-11-16 07:12AM  SPECTRUM PHARMACEUTICALS INC Files SEC form 8-K, Other Events +5.85%
Mar-10-16 11:08AM  Spectrum (SPPI) Incurs Narrower-than-Expected Loss in Q4 +9.18%
Mar-09-16 10:59PM  Edited Transcript of SPPI earnings conference call or presentation 9-Mar-16 9:30pm GMT
04:13PM  Spectrum Pharma reports 4Q loss
04:09PM  SPECTRUM PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements
04:00PM  Spectrum Pharmaceuticals Reports Fourth Quarter 2015 and Full Year 2015 Financial Results and Pipeline Update Business Wire
07:07AM  Q4 2015 Spectrum Pharmaceuticals Inc Earnings Release - After Market Close
Mar-08-16 02:18PM  Spectrum Pharmaceuticals, Inc. Value Analysis (NASDAQ:SPPI) : March 8, 2016 -5.41%
Mar-07-16 08:21AM  Spectrum Pharmaceuticals, Inc. breached its 50 day moving average in a Bullish Manner : SPPI-US : March 7, 2016 +6.14%
07:00AM  Spectrum Pharmaceuticals Initiates Phase 2 Breast Cancer Trial for Poziotinib, a Novel Pan-HER Inhibitor Business Wire
Mar-02-16 07:00AM  Spectrum Pharmaceuticals Announces Fourth Quarter and Full Year 2015 Financial Results Teleconference and Webcast Business Wire +7.74%
Feb-22-16 08:00AM  Biotechnology Stocks under Review -- Alnylam Pharma, Puma Biotechnology, Regeneron Pharma, and Spectrum Pharma Accesswire
07:00AM  Spectrum Pharmaceuticals to Present Corporate Update at 2016 RBC Capital Markets' Global Healthcare Conference on February 24 Business Wire
Feb-19-16 09:00AM  Labaton Sucharow LLP Announces Summary Notice Of Pendency Of Class Action, Proposed Settlement, And Motion For Attorneys' Fees And Expenses In In Re: Spectrum Pharmaceuticals, Inc., Securities Litigation PR Newswire +5.17%
07:00AM  Spectrum Pharmaceuticals Announces FDAs Acceptance of NDA Filing for EOquin® (apaziquone for intravesical instillation) Business Wire
Feb-01-16 07:21PM  Spectrum (SPPI) Initiates Phase III Study on SPI-2012
Spectrum Pharmaceuticals, Inc., a biotechnology company, develops and commercializes oncology and hematology drug products. The company markets six drug products, including FUSILEV for patients with metastatic colorectal cancer, rescue after high-dose methotrexate therapy in osteosarcoma, and to diminish the toxicity and counteract the effects of impaired methotrexate elimination and of inadvertent overdosage of folic acid antagonists; FOLOTYN, a folate analogue metabolic inhibitor to treat patients with relapsed or refractory PTCL; ZEVALIN injection for patients with follicular non-Hodgkin's lymphoma; MARQIBO, a sphingomyelin/cholesterol liposome-encapsulated formulation of the anticancer drug vincristine for adult patients with Philadelphia chromosome-negative acute lymphoblastic leukemia; BELEODAQ injection for patients with relapsed or refractory PTCL; and EVOMELA for use as a conditioning treatment prior to autologous stem cell transplant in multiple myeloma patients. It is also developing POZIOTINIB for treating breast, gastric, colorectal, and lung cancers; EOQUIN for non-muscle invasive bladder cancer; and SPI-2012 for chemotherapy-induced neutropenia in patients with breast cancer. The company sells its drugs through a direct sales force in the United States; and through distributors in Europe. It has licensing and development agreement with Cell Therapeutics, Inc.; license agreement with Merck & Cie AG, Sloan-Kettering Institute, and Cydex Pharmaceuticals, Inc.; development and commercialization collaboration agreement with Allergan, Inc.; collaboration agreement with Nippon Kayaku Co., Ltd.; licensing and collaboration agreement with TopoTarget A/S; and co-development and commercialization agreement with Hanmi Pharmaceutical Company. The company was formerly known as NeoTherapeutics, Inc. and changed its name to Spectrum Pharmaceuticals, Inc. in December 2002. Spectrum Pharmaceuticals, Inc. was founded in 1987 and is headquartered in Henderson, Nevada.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
SHROTRIYA RAJESH C MDChairman & CEODec 22Option Exercise4.23129,248546,719101,426Dec 23 04:03 PM
Krassner Stuart MitchellDirectorDec 01Option Exercise4.2615,00063,90052,988Dec 02 04:48 PM